Supply chain challenges & opportunities

This eHandbook explores what companies can do to prepare for these challenges as well as the opportunities to mitigate the impacts, including the use of technology such as artificial intelligence and machine learning to optimize supply chains, inventory, and logistics.

Sept. 18, 2025

Sponsored

The resiliency of pharmaceutical supply chains has never been more important and in many ways more vulnerable. From shifting global trade dynamics to inflation trends to interest rate cuts, several macroeconomic factors continue to impact pharma supply chains. While generic medicines are the backbone of the U.S. drug market, making up approximately 90% of prescription volume, they represent a particularly vulnerable segment of the supply chain.

At the same time, contract development and manufacturing organizations (CDMOs) are faced with shifting demand, tighter regulations, and growing complexity in sterile injectable supply chains. This eHandbook explores what companies can do to prepare for these challenges as well as the opportunities to mitigate the impacts, including the use of technology such as artificial intelligence and machine learning to optimize supply chains, inventory, and logistics.